Safety of enteral naloxone and i.v. neostigmine when used to relieve constipation

Am J Health Syst Pharm. 2003 Jun 15;60(12):1264-7. doi: 10.1093/ajhp/60.12.1264.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study

MeSH terms

  • Administration, Oral
  • Administration, Rectal
  • Adolescent
  • Adult
  • Aged
  • Arrhythmias, Cardiac / chemically induced
  • Colic / chemically induced
  • Constipation / drug therapy*
  • Dizziness / chemically induced
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Hypertension / chemically induced
  • Hypotension / chemically induced
  • Infusions, Intravenous
  • Injections, Intravenous
  • Injections, Subcutaneous
  • Intubation, Gastrointestinal / methods
  • Male
  • Middle Aged
  • Naloxone / administration & dosage*
  • Naloxone / adverse effects
  • Narcotic Antagonists / administration & dosage*
  • Narcotic Antagonists / adverse effects
  • Nausea / chemically induced
  • Neostigmine / administration & dosage*
  • Neostigmine / adverse effects
  • Parasympathomimetics / administration & dosage*
  • Parasympathomimetics / adverse effects
  • Retrospective Studies
  • Treatment Outcome

Substances

  • Narcotic Antagonists
  • Parasympathomimetics
  • Naloxone
  • Neostigmine